Best Weight Loss Pills: A Patient's Guide to Prescription and OTC Options

The most effective weight loss pills are FDA-approved prescription medications. The newest options are GLP-1 receptor agonist tablets — oral semaglutide (Wegovy Pill) and orforglipron (Foundayo) — which produced roughly 10–15% average body weight loss in clinical trials [1][2]. Older FDA-approved prescription pills — phentermine-topiramate (Qsymia) and bupropion-naltrexone (Contrave) — average 5–10% loss [3][4]. Orlistat 60 mg (Alli) is the only FDA-approved over-the-counter weight loss pill, with smaller average results [5]. Individual results vary, and every pill has side effects and contraindications.

What counts as a "weight loss pill"?

"Weight loss pill" is a broad term. It can mean an FDA-approved prescription drug, an FDA-approved over-the-counter (OTC) drug sold at a pharmacy, or a dietary supplement sold online or at a vitamin store. These categories are very different in how they're tested, regulated, and how well they work.

FDA-approved prescription oral medications

Prescription weight loss pills are FDA-approved drugs that require a clinician's evaluation and a prescription. They have been tested in randomized clinical trials and carry FDA labeling that lists who they're approved for, how they work, side effects, and contraindications [6].

FDA-approved over-the-counter (OTC) options

Only one weight loss pill is FDA-approved for OTC use: orlistat 60 mg, sold as Alli [5]. You can buy it without a prescription, but it is still a regulated drug with FDA labeling and listed side effects.

Dietary supplements vs. approved drugs

Dietary supplements — green tea extract, garcinia, raspberry ketones, "fat burners" — are regulated as food, not drugs. The FDA does not review them for safety or effectiveness before they're sold, and most have little or no high-quality evidence that they produce meaningful weight loss [7].

Which weight loss pill is the most effective?

Across published phase 3 trial data, GLP-1 receptor agonist pills currently produce the largest average weight loss among FDA-approved oral medications — roughly 10–15% of body weight over about a year [1][2]. Older oral medications produce smaller but still meaningful average results, and side effect profiles differ substantially. Individual results vary.

FDA-approved GLP-1 oral pills (Wegovy Pill, Foundayo)

Oral semaglutide (Wegovy Pill) is a tablet form of semaglutide, a GLP-1 receptor agonist — the same drug class as Wegovy and Ozempic injections [1]. In the OASIS-4 trial, adults with overweight or obesity lost an average of about 13–15% of body weight on the higher oral dose, compared with about 2% on placebo, over 68 weeks [1]. Common side effects in trials were nausea, vomiting, diarrhea, and constipation; the FDA label includes warnings about pancreatitis, gallbladder disease, and a boxed warning about thyroid C-cell tumors observed in rodent studies. It is contraindicated in people with a personal or family history of medullary thyroid carcinoma or MEN 2 syndrome [1].

Orforglipron (Foundayo) is a once-daily, non-peptide oral GLP-1 receptor agonist FDA-approved for chronic weight management. In the ATTAIN-1 phase 3 trial, adults without diabetes lost roughly 10–12% of body weight on the highest dose over 72 weeks [2]. Because orforglipron is a small molecule rather than a peptide, it does not require an empty stomach or water restrictions [2]. The most common side effects were gastrointestinal — nausea, vomiting, diarrhea, and constipation — and the label carries the same boxed warning and contraindications regarding medullary thyroid carcinoma and MEN 2 as other GLP-1 receptor agonists [2].

Phentermine-topiramate (Qsymia)

Qsymia combines phentermine (an appetite suppressant) and topiramate (a seizure and migraine drug that also reduces appetite). In phase 3 trials, average weight loss was about 8–10% over a year on the higher dose [3][6]. Side effects can include tingling in hands and feet, dry mouth, taste changes, trouble sleeping, and mood changes. Topiramate is associated with birth defects (cleft lip and palate), so the FDA label requires reliable contraception for people who could become pregnant. It is contraindicated in pregnancy, glaucoma, hyperthyroidism, and recent MAO inhibitor use [6].

Bupropion-naltrexone (Contrave)

Contrave combines bupropion (an antidepressant and stop-smoking medication) and naltrexone (approved for alcohol and opioid use disorder). In phase 3 trials, average weight loss was about 5–9% over a year [4][6]. Common side effects include nausea, constipation, headache, dizziness, and trouble sleeping. The FDA label carries a boxed warning about suicidal thoughts and behaviors in younger adults due to bupropion, and the drug is contraindicated in uncontrolled hypertension, seizure disorders, eating disorders, chronic opioid use, and during abrupt discontinuation of alcohol or sedatives [6].

Orlistat (Xenical, Alli)

Orlistat blocks about 25–30% of the fat in food from being absorbed in the gut. Prescription Xenical is the higher-strength version; Alli is the OTC version at half the strength [5]. Average weight loss is about 3–5% with Alli and 5–10% with Xenical when paired with a reduced-fat diet [3][5]. The most common side effects are oily stools, gas, and urgent bowel movements, especially after high-fat meals. Orlistat can reduce absorption of fat-soluble vitamins and is contraindicated in chronic malabsorption syndromes, cholestasis, and pregnancy [5].

How do prescription weight loss pills compare?

The table below summarizes FDA-approved oral (and, for reference, one injectable) options for chronic weight management, plus one telehealth access path so patients can see how delivery models compare on price and process. Weight-loss ranges are averages from pivotal trials; individual results vary.

Are GLP-1 pills as effective as the injections?

Oral GLP-1s are effective, but injectable versions have produced somewhat larger average weight loss in published phase 3 trials. Both formats share the same drug-class side effects — nausea, vomiting, diarrhea, constipation — and the same contraindications, including a personal or family history of medullary thyroid carcinoma or MEN 2 [1][9].

Oral semaglutide vs. Wegovy injection

Wegovy injection (semaglutide, dosed weekly) produced about 15% average weight loss over 68 weeks in the STEP-1 trial [9]. Oral semaglutide at the higher dose produced about 13–15% in OASIS-4 [1]. The two are roughly comparable on average, though individual results vary and the injection has a longer real-world track record.

Orforglipron vs. tirzepatide (Zepbound)

Tirzepatide (Zepbound), a weekly injection that activates both GLP-1 and GIP receptors, produced about 20–21% average weight loss over 72 weeks in the SURMOUNT-1 trial [10]. Orforglipron's roughly 10–12% in ATTAIN-1 is meaningfully smaller on average [2] — but it's a once-daily pill. Tirzepatide's FDA label lists the same boxed warning and GLP-1-class contraindications, plus warnings about pancreatitis, gallbladder disease, and severe gastrointestinal effects [10].

When access to brand-name GLP-1s is a barrier, some patients work with their clinician to consider compounded semaglutide or compounded tirzepatide prepared by a state-licensed 503A pharmacy. Compounded GLP-1s are not FDA-approved products; they are prepared for an identified patient based on a clinician's prescription, and the same drug-class side effects and contraindications apply [12].

Who qualifies for prescription weight loss pills?

BMI and health criteria

FDA-approved chronic weight management pills are generally indicated for adults with [6]:

• A body mass index (BMI) of 30 or higher (obesity), or
• A BMI of 27 or higher (overweight) plus at least one weight-related condition such as type 2 diabetes, high blood pressure, high cholesterol, or obstructive sleep apnea.

Some pills, such as Qsymia and Saxenda, are also FDA-approved for certain adolescents [6][8]. Setmelanotide (Imcivree) is approved only for rare genetic forms of obesity (such as POMC, PCSK1, or LEPR deficiency, or Bardet-Biedl syndrome) [11].

Who should not take them

Each drug has its own FDA-labeled contraindications. As general examples [1][2][5][6]:

• GLP-1 pills are contraindicated in people with a personal or family history of medullary thyroid carcinoma or MEN 2 syndrome [1][2].
• Phentermine-containing pills are contraindicated in uncontrolled hypertension, cardiovascular disease, hyperthyroidism, glaucoma, and recent MAO inhibitor use [6].
• Contrave is contraindicated in uncontrolled hypertension, seizure disorders, eating disorders, chronic opioid use, and abrupt alcohol or sedative discontinuation [6].
• Orlistat is contraindicated in chronic malabsorption syndromes and cholestasis [5].
• All chronic weight management pills are contraindicated in pregnancy [1][2][5][6].

What are the side effects and risks?

Every effective weight loss pill has trade-offs. Knowing them up front helps you and your clinician choose the right option. The list below summarizes labeled side effects from FDA prescribing information and pivotal trials.

• GLP-1 pills (Wegovy Pill, Foundayo): nausea, vomiting, diarrhea, constipation, reflux. Labeled warnings include pancreatitis, gallbladder disease, acute kidney injury from dehydration, and a boxed warning about thyroid C-cell tumors observed in rodent studies [1][2].
• Qsymia (phentermine-topiramate): tingling in hands and feet, dry mouth, taste changes, trouble sleeping, mood changes, elevated heart rate. Topiramate is associated with birth defects [6].
• Contrave (bupropion-naltrexone): nausea, constipation, headache, dizziness, trouble sleeping. Boxed warning for suicidal thoughts and behaviors in younger adults [6].
• Orlistat (Alli, Xenical): oily or loose stools, gas, fecal urgency, especially after fatty meals; reduced absorption of fat-soluble vitamins; rare reports of severe liver injury [5].
• Phentermine alone: increased heart rate and blood pressure, jitteriness, insomnia, dependence potential. FDA-approved only for short-term use (≤12 weeks) [6].

What about over-the-counter pills and supplements?

Alli (orlistat 60 mg)

Alli is the only OTC weight loss pill the FDA has approved. It works the same way as prescription Xenical at half the dose and is FDA-labeled for adults with a BMI of 25 or higher, used together with a reduced-calorie, reduced-fat diet [5]. Labeled side effects include oily stools, gas, and fecal urgency, and it can reduce absorption of fat-soluble vitamins [5].

Fiber, green tea extract, and other supplements

Some supplements have modest evidence for small effects. Soluble fiber (such as psyllium or glucomannan) may slightly increase fullness. Caffeine and green tea extract may slightly increase short-term calorie burn. None come close to the effect size of FDA-approved prescription medications, and product quality varies because supplements are not FDA-reviewed for safety or effectiveness before sale [7].

Why "fat burner" supplements rarely work

Most products marketed as "fat burners," "metabolism boosters," or "appetite blockers" have not been studied in well-designed human trials. Because supplements are not FDA-reviewed before sale, the dose and even the listed ingredients are not always accurate [7]. If a product promises rapid or dramatic weight loss, treat that as a red flag.

How do I get a prescription weight loss pill — and what does it cost?

Getting a prescription starts with a clinical evaluation. A licensed clinician will review your BMI, health conditions, current medications, and goals to decide which pill — if any — is appropriate. They will also screen for the contraindications listed earlier.

Common paths include your primary care clinician, an obesity-medicine specialist, or a licensed telehealth service. Chia is one such telehealth option, offering clinician-reviewed evaluations for FDA-approved weight management medications and, when clinically appropriate, compounded GLP-1s (semaglutide or tirzepatide) dispensed through US-based 503A pharmacy partners with third-party potency and sterility testing and transparent pricing. It is one path among several; the right choice depends on your insurance, preferences, and health.

Approximate monthly cost ranges in the US, before insurance:

• Generic phentermine: ~$25–50
• Generic orlistat / Alli OTC: ~$40–80
• Contrave: ~$100–200
• Qsymia: ~$100–200
• Brand GLP-1 pills (Wegovy Pill, Foundayo): ~$500–1,000+
• Compounded GLP-1s via 503A pharmacy: varies by pharmacy and formulation

Insurance coverage for weight loss pills varies widely. Many commercial plans do not cover chronic weight management drugs, and Medicaid coverage depends on the state. Your clinician's office or pharmacist can help check coverage before you fill a prescription.

Frequently asked questions

Keep reading

Weight Loss

Weight Loss Drugs Online: How Telehealth Prescribing Works in 2026

Weight Loss

Prescription Weight Loss Drugs: A Guide to FDA-Approved Options

GLP-1 Weight Loss

How to Get Weight Loss Injections: A Step-by-Step Guide